Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma

AIM: To evaluate the efficacy of dual versus single immune checkpoint inhibitors (ICI) in BRAF wild-type advanced melanoma patients. MATERIALS & METHODS: A retrospective study of all advanced BRAF wild-type melanoma patients on palliative-intent ICI between 2015 and 2020 (n = 67). RESULTS: Dual...

Descripción completa

Detalles Bibliográficos
Autores principales: Kartolo, Adi, Yeung, Cynthia, Kuksis, Markus, Hopman, Wilma, Baetz, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043874/
https://www.ncbi.nlm.nih.gov/pubmed/35497071
http://dx.doi.org/10.2217/mmt-2021-0005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043874/
https://www.ncbi.nlm.nih.gov/pubmed/35497071
http://dx.doi.org/10.2217/mmt-2021-0005

Ejemplares similares